Tag: Perforomist
ASP: Budesonide reverses course
December 11, 2013HME News Staff
BALTIMORE - When it comes to nebulizer medication pricing, one quarter you're up; another quarter you're down.Average sales price (ASP) figures for the first quarter of 2014 revealed a decrease for budesonide (J7626) of nearly 35 cents to $5.60 per dose. That's in contrast to the previous quarter, when the drug increased 85 cents.The only other drugs to see increases for the upcoming quarter: brand names Brovana (J7605) and Perforomist (J7606), which increased 22 cents and 6 cents, respectively....
Prices, audits stay the course
April 23, 2012Theresa Flaherty, Managing Editor
BALTIMORE - Brand-name Brovana took a hit in the latest average sales price (ASP) figures for nebulizer medications, but otherwise there were few major changes.
The long-acting beta agonist Brovana (J7605) decreased 24 cents to $5.11 per dose in the latest figures, released in March.
Between the lower reimbursement and a price increase from the manufacturer, you won't see many providers supplying the drug, said Sam Jarczynski, who blames market consolidation for the change.
“There...